Nipro Overview

  • Founded
  • 1954
Founded
  • Status
  • Public
  • Employees
  • 33,915
Employees
  • Stock Symbol
  • 8086
Stock Symbol
  • Investments
  • 22
  • Share Price
  • $11.63
  • (As of Friday Closing)

Nipro General Information

Description

Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Contact Information

Website
www.nipro.co.jp
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Medical Supplies
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • 3-9-3 Honjo-Nishi Kita-ku
  • Osaka, 531-8510
  • Japan
+81 00-0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nipro Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$11.63 $11.84 $8.55 - $12.94 $1.9B 163M 564K -$0.72

Nipro Financials Summary

In Thousands,
USD 		TTM 30-Sep-2020 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018
EV 6,394,565 6,174,147 5,982,270 5,906,481
Revenue 4,099,234 4,069,768 3,845,828 3,566,859
EBITDA 322,216 315,214 562,697 505,065
Net Income (117,701) (112,947) 109,458 106,709
Total Assets 8,406,270 7,697,247 7,628,290 7,776,866
Total Debt 5,627,495 5,008,834 4,897,813 4,935,018
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nipro Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in f
Medical Supplies
Osaka, Japan
33,915 As of 2020

00000000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliq
000000000000000
Bad Homburg, Germany
0000 As of 0000

00000000

tate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proide
000000000000000
Brentford, United Kingdom
00000 As of 0000
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nipro Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Fresenius Kabi Corporate Backed or Acquired Bad Homburg, Germany 0000
000000000000000 Corporation Brentford, United Kingdom 00000 00000000000
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
000000000 0000000 Corporation Bad Homburg, Germany 000000 00000000
00000000 Corporation Basel, Switzerland 000000 000000000000
You’re viewing 5 of 17 competitors. Get the full list »

Nipro Executive Team (4)

Name Title Board Seat Contact Info
Yoshihiko Sano President and Representative Director
Goichi Miyazumi President
Toshiaki Masuda Managing Director
To view Nipro’s complete executive team members history, request access »

Nipro Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nipro Investments & Acquisitions (22)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000000 28-Oct-2020 0000 00000 00.00 Therapeutic Devices 00000000 000000
0000000 000 03-Mar-2020 000000000000000000 Specialty Chemicals 000000 00000000
00 00000000 18-Jan-2017 00000 00000 00 00.000 Biotechnology
000000000 31-Oct-2015 000000000000000000 0000 Diagnostic Equipment 000000000 0000
Atonarp 12-Aug-2014 Early Stage VC 000 Electronic Equipment and Instruments
You’re viewing 5 of 22 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Nipro Subsidiaries (7)

Company Name Industry Location Founded
Dimesol USA Specialty Chemicals Lewisberry, PA 2016
0000 0000000 & 000 Biotechnology Aoba-ku, Japan 0000
000000000 Diagnostic Equipment Burlington, MA 0000
00000 000000 Acquirer Mechelen, Belgium 0000
0.0. 00000 Pharmaceuticals Lancaster, NH 0000
You’re viewing 5 of 7 subsidiaries. Get the full list »

Nipro Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 000000 15-Mar-2010 000000000000000000 00000 Completed
  • 00000
000000000 07-Oct-2008 00000 00000 00 00.000 Completed
  • 5 buyers
Bipha 01-Feb-2001 Secondary Transaction - Private Completed
To view Nipro’s complete exits history, request access »